Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany.

Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany.

<h4>Background</h4>Patient decisions to take preventative treatments for osteoporosis depend on their perceptions of fracture risk, medication effect sizes (ES) of benefits and harms. However, physicians and lay persons may have differing perceptions of risks and medication efficacy. Bot...

Full description

Bibliographic Details
Main Authors: Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0272985

Internet

https://doi.org/10.1371/journal.pone.0272985

Similar Items